Search
Silatecan
go.drugbank.com/drugs/DB12384InvestigationalSilatecan has been used in trials studying the treatment of GBM, Tumors, Gliosarcoma, Solid Malignancies, and Glioblastoma Multiforme, among others.
AZD3409
go.drugbank.com/drugs/DB04893ExperimentalAZD3409 is a farnesyl-transferase inhibitor (FAR) indicated for the treatment of solid tumors. Phase I trials were initiated January 2003, and were ongoing as of February 2004. As of February 2007 the development of AZD3409 had been disc...
Ulotaront
go.drugbank.com/drugs/DB15665Investigational[L12891] An initial clinical study has shown this drug may be effective against both positive and negative symptoms of schizophrenia. … Unlike other drugs used for this condition, SEP-363856 does not bind to the dopamine D2 receptors, but exerts actions on the trace amine–associated receptor 1 (TAAR1) and 5-hydroxytryptamine type 1A (5
2-phospho-D-glyceric acid
go.drugbank.com/drugs/DB01709ExperimentalA 2-phosphoglyceric acid in which the glyceric acid moiety has D (R) configuration.
Afuresertib
go.drugbank.com/drugs/DB11648InvestigationalAfuresertib has been used in trials studying the treatment of Cancer and Neoplasms, Haematologic.
PF-03758309
go.drugbank.com/drugs/DB11775InvestigationalPF-03758309 has been used in trials studying the treatment of Advanced Solid Tumors.
Balaglitazone
go.drugbank.com/drugs/DB12781InvestigationalBalaglitazone has been used in trials studying the treatment of Diabetes Mellitus, Type 2.
Terpinen-4-ol
go.drugbank.com/drugs/DB12816InvestigationalTerpinen-4-ol is under investigation in clinical trial NCT01647217 (Demodex Blepharitis Treatment Study).
Eltoprazine
go.drugbank.com/drugs/DB12883InvestigationalEltoprazine has been used in trials studying the treatment of Schizophrenia and Cognitive Impairment.
Granotapide
go.drugbank.com/drugs/DB12934InvestigationalGranotapide has been used in trials studying the treatment of Type II Diabetes Mellitus.